Add like
Add dislike
Add to saved papers

Glomerular filtration rate as a prognostic factor for long-term mortality after acute pulmonary embolism.

OBJECTIVE: <br>To determine the impact of estimated glomerular filtration rate (eGFR) and creatinine clearance (CrCl) on long-term all-cause mortality following acute PE in association with other routine laboratory analyses and comorbidities.<br> Materials (Subjects) and Methods<br>The prospective study enrolled 141 consecutive patients presenting with objectively confirmed acute PE. Demographic, clinical data, comorbidities and laboratory values were recorded. CrCl and GFR was estimated using Cockcroft-Gault, MDRD and CKD-EPI equations. Patients were followed up at 90 days and one year after the event.<br> Results: <br>In univariate analyses, age, active cancer, pulmonary embolism severity index (PESI), CrCl and eGFR, D-dimer value, and high-density lipoprotein level were found to be significantly associated with mortality in 90 days and one year. Additionally, body-mass index was significant in one-year follow-up. CrCl by Cockcroft-Gault (90-day: AUC=0.763; one-year: AUC=0.718) demonstrated higher discriminatory power for predicting mortality than eGFR by MDRD (AUC=0.686; AUC=0.609) and CKD-EPI (AUC=0.697; AUC=0.630) equations. In multivariate analyses, active cancer, CrCl by Cockcroft-Gault (90-day: HR 0.948, 95% CI 0.919-0.979; one-year: HR 0.967, 95% CI 0.943-0.991), eGFR by CKD-EPI (90-day: HR 0.948, 95% CI 0.915-0.983; one-year: HR 0.971, 95% CI 0.945-0.998) were found to be independent predictors for mortality. eGFR by MDRD, D-dimer and PESI value were significant prognostic factors for 90-day mortality.<br> Conclusion:<br>Decreased renal function is a prognostic factor for increased all-cause mortality in 90 days and one year after acute PE.<br>.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app